Zobrazeno 1 - 10
of 46
pro vyhledávání: '"I E, Bergmann"'
Publikováno v:
Expert Review of Vaccines. 20:13-22
Introduction: Vaccination against foot-and-mouth disease virus is regarded as the most effective way to prevent disease. Selection of appropriate vaccine strains is challenging due to lack of cross-protection between serotypes and incomplete protecti
Autor:
A.M. Espinoza, Viviana Malirat, K.N. Lee, Eduardo Maradei, I. E. Bergmann, J.H. Park, Andrea Pedemonte, Eliana Smitsaart, S. Galdo Novo
Publikováno v:
Vaccine. 36:1570-1576
In 2010 serotype O foot-and-mouth disease virus of the Mya98 lineage/SEA topotype spread into most East Asian countries. During 2010–2011 it was responsible for major outbreaks in the Republic of Korea where a monovalent O/Manisa vaccine (belonging
Publikováno v:
Archives of Virology. 162:2279-2286
Recombinant protein 3A-EGFP, a fusion construct between foot-and-mouth disease virus (FMDV) non-structural protein 3A and the enhanced green fluorescent protein (EGFP) was expressed in BL21-DE3 cells. The identity of the partially purified protein 3A
Autor:
A.M. Espinoza, Viviana Malirat, Eduardo Maradei, Andrea Pedemonte, Eliana Smitsaart, S. Galdo Novo, I. E. Bergmann, Nora Mattion
Publikováno v:
Vaccine. 35:2303-2307
Identifying vaccine strains to control outbreaks of foot-and-mouth disease virus that could spread to new regions is essential for contingency plans. This is the first report on the antigenic/immunogenic relationships of the South American O1/Campos
Autor:
S, Galdo Novo, V, Malirat, E D, Maradei, A R, Pedemonte, A M, Espinoza, E, Smitsaart, K N, Lee, J H, Park, I E, Bergmann
Publikováno v:
Vaccine. 36(12)
In 2010 serotype O foot-and-mouth disease virus of the Mya98 lineage/SEA topotype spread into most East Asian countries. During 2010-2011 it was responsible for major outbreaks in the Republic of Korea where a monovalent O/Manisa vaccine (belonging t
Autor:
S, Galdo Novo, V, Malirat, E D, Maradei, A M, Espinoza, E, Smitsaart, A R, Pedemonte, N, Mattion, I E, Bergmann
Publikováno v:
Vaccine. 35(18)
Identifying vaccine strains to control outbreaks of foot-and-mouth disease virus that could spread to new regions is essential for contingency plans. This is the first report on the antigenic/immunogenic relationships of the South American O1/Campos
Autor:
Claudio Cesar Cirne-Santos, Alice M. R. Bernardino, Izabel Christina Nunes de Palmer Paixão, Helena Carla Castro, M. A. Rebello, Marcelo Damião Ferreira de Meneses, Julio C. Borges, Davis Fernandes Ferreira, Alessandra Mendonça Teles de Souza, Viviana Malirat, Raquel Amorim, Marcos Vinícius Palmeira de Mello, Renata de Mendonça Campos, Luiz C. S. Pinheiro, Lucio Ayres Caldas, I. E. Bergmann
Publikováno v:
Archives of virology. 162(6)
Mayaro virus (MAYV) is an arthropod-borne virus and a member of the family Togaviridae, genus Alphavirus. Its infection leads to an acute illness accompanied by long-lasting arthralgia. To date, there are no antiviral drugs or vaccines against infect
Autor:
M. A. Rebello, José Júnior França de Barros, Viviana Malirat, Eliane Veiga da Costa, I. E. Bergmann
Publikováno v:
Veterinary Microbiology. 120:50-62
Genetic variation of foot-and-mouth disease virus (FMDV) isolates, serotype O, recovered serially over a 1-year period from persistently infected buffalos was assessed. The persistent state was established experimentally with plaque-purified FMDV, st
Autor:
I. E. Bergmann, E. Neitzert, Bernd Haas, Aldo Dekker, Matthias Greiner, H. Yadin, Emiliana Brocchi, F. De Simone, D. Sammin, David J. Paton, N. Bulut, K. De Clercq, Viviana Malirat, Nesya Goris, Santina Grazioli, Satya Parida, K.J. Sorensen
Publikováno v:
Vaccine 24 (2006) 47-48
Vaccine, 24(47-48), 6966-6979
Vaccine, 24(47-48), 6966-6979
To validate the use of serology in substantiating freedom from infection after foot-and-mouth disease (FMD) outbreaks have been controlled by measures that include vaccination, 3551 sera were tested with six assays that detect antibodies to the non-s
Autor:
I. E. Bergmann, Matthias Greiner, Emiliana Brocchi, David J. Paton, Satya Parida, Simon Gubbins, D. Sammin, Aldo Dekker, Kris De Clercq
Publikováno v:
Vaccine 24 (2006) 42-43
Vaccine, 24(42-43), 6503-6512
Vaccine, 24(42-43), 6503-6512
There has been much debate about the use of the so-called ¿vaccinate-to-live¿ policy for the control of foot-and-mouth disease (FMD) in Europe, according to which, spread of the FMD virus (FMDV) from future outbreaks could be controlled by a short